.Pharmacolibrary.Drugs.V_Various.V06D_OtherNutrients.V06DC01_Glucose.Glucose .Pharmacolibrary.Drugs.V_Various.V06D_OtherNutrients.V06DC01_Glucose.Glucose| name: | Glucose |
| ATC code: | V06DC01 | route: | intravenous |
| n-compartments | 1 |
Glucose is a simple monosaccharide sugar that is an essential energy source in living organisms and a critical component of metabolism. It is used medically to treat hypoglycemia, as a caloric supplement in parenteral nutrition, and as an ingredient in oral rehydration solutions. Intravenous glucose infusion is approved and widely used in clinical practice.
Estimated pharmacokinetic parameters for intravenous glucose in healthy adult humans, based on literature review and clinical reference data. No directly referenced population PK studies for this ATC code/glucose as a drug product.
Graham, GG, et al., & Williams, KM (2011). Clinical pharmacokinetics of metformin. Clinical pharmacokinetics 50(2) 81–98. DOI:10.2165/11534750-000000000-00000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21241070
Alshaer, MH, et al., & Hosmann, A (2022). Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue. Antimicrobial agents and chemotherapy 66(8) e0043822–None. DOI:10.1128/aac.00438-22 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35862739
Ng, CM, et al., & De León, DD (2018). Population pharmacokinetics of exendin-(9-39) and clinical dose selection in patients with congenital hyperinsulinism. British journal of clinical pharmacology 84(3) 520–532. DOI:10.1111/bcp.13463 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29077992